DFX Intelligence

Data Factory

RIA / WealthPrivate fundprivate equity fund3(c)(7)dropped

RPS BIOPHARMA INVESTMENTS, LP

advised by RP MANAGEMENT, LLC

Cayman Islands

This is the graph view. The full profile, with its team, deals and sources, is on RIA / Wealth Management.Open the full profile →

Search this name across graphsid dfx:ria:5bb244ab-3ba0-e795-b71d-6c5145b4c12d

Data as of Mar 30, 2021 (this record's last observation) from federal regulator filings. Page built Sep 19, 2026, 11:50 PM UTC and rebuilt at most every 15 minutes.

Relationships: 1
Dated events: 0
On other graphs: 1
Observed: Mar 29, 2018 to Mar 30, 2021
5 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

RPS Biopharma Investments, LP

Private equity fund · shared adv fund id

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Adviser: RP MANAGEMENT, LLCCRD 161569
Fund type: Private Equity Fund
Latest reported GAV: $29.6Mgross asset value on Schedule D 7.B(1), as of 2021-03-30; never fund size
Peak reported GAV: $111M
Beneficial owners: 57
Minimum investment: $0
Owned by the adviser: 8300%
Owned by funds of funds: 0%
Owned by non-US persons: 5200%
Clients solicited: no
Form D file number: 021-284414an SEC offering identifier; the Form D vehicle on the venture or private equity graph is linked above when the identity layer has it
Organised in: Cayman Islands
First reported: Mar 29, 2018
Last reported: Mar 30, 2021fund reporting on the SEC extract ends 2024-12-31
Filings reporting it: 5
Fund id: 805-9037795495

Reported gross asset value by filing

each Schedule D 7.B(1) row as filed; GAV is gross asset value, never fund size

Filed	GAV	Owners	Minimum	Adviser owns	Audited	Name as filed
Mar 30, 2021	$29.6M	57	$0	8300.0%	yes	RPS BIOPHARMA INVESTMENTS, LP
Mar 27, 2020	$49.5M	56	$0	6900.0%	yes	RPS BIOPHARMA INVESTMENTS, LP
Sep 16, 2019	$80.0M	56	$0	6900.0%	yes	RPS BIOPHARMA INVESTMENTS, LP
Mar 29, 2019	$80.0M	56	$0	6900.0%	yes	RPS BIOPHARMA INVESTMENTS, LP
Mar 29, 2018	$111M	51	$0	4300.0%	yes	RPS BIOPHARMA INVESTMENTS, LP

Custodians

Schedule D 7.B(1) question 25, as filed

Custodian	Legal name	City	State	Country	Related person	SEC number
BANK OF AMERICA	BANK OF AMERICA	NEW YORK	New York	United States	no	n/a

Relationships

Advises (1)

← RP MANAGEMENT, LLCRegistered adviserPrivate Equity Fund, IA, no longer reported
Mar 29, 2018 to Mar 30, 2021factForm ADV

Dated events

No dated event names this entity yet.

Provenance

Graph: RIA / Wealth Management
Canonical id: dfx:ria:5bb244ab-3ba0-e795-b71d-6c5145b4c12d
First observed: Mar 29, 2018
Last observed: Mar 30, 2021 66 months ago
Source families: Federal regulator filings
1 registered feed stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

RPS BIOPHARMA INVESTMENTS, LP

advised by RP MANAGEMENT, LLC

Cayman Islands

This is the graph view. The full profile, with its team, deals and sources, is on RIA / Wealth Management.Open the full profile →

Search this name across graphsid dfx:ria:5bb244ab-3ba0-e795-b71d-6c5145b4c12d

Data as of Mar 30, 2021 (this record's last observation) from federal regulator filings. Page built Sep 19, 2026, 11:50 PM UTC and rebuilt at most every 15 minutes.

Filed

GAV

Owners

Minimum

Adviser owns

Audited

Name as filed

Mar 30, 2021

$29.6M

8300.0%

yes

RPS BIOPHARMA INVESTMENTS, LP

Mar 27, 2020

$49.5M

6900.0%

yes

RPS BIOPHARMA INVESTMENTS, LP

Sep 16, 2019

$80.0M

6900.0%

yes

RPS BIOPHARMA INVESTMENTS, LP

Mar 29, 2019

$80.0M

6900.0%

yes

RPS BIOPHARMA INVESTMENTS, LP

Mar 29, 2018

$111M

4300.0%

yes

RPS BIOPHARMA INVESTMENTS, LP

Custodian

Legal name

City

State

Country

Related person

SEC number

BANK OF AMERICA

NEW YORK

New York

United States

n/a